Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2019 - 2022)

SELLAS Life Sciences (SLS) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $170000.0 as the latest value for Q3 2022.

  • On a quarterly basis, Other Non-Current Liabilities fell 96.62% to $170000.0 in Q3 2022 year-over-year; TTM through Sep 2022 was $170000.0, a 96.62% decrease, with the full-year FY2021 number at $296000.0, down 93.61% from a year prior.
  • Other Non-Current Liabilities was $170000.0 for Q3 2022 at SELLAS Life Sciences, down from $181000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $5.2 million in Q2 2020 to a low of $170000.0 in Q3 2022.
  • A 4-year average of $3.7 million and a median of $4.8 million in 2019 define the central range for Other Non-Current Liabilities.
  • Peak YoY movement for Other Non-Current Liabilities: increased 8.01% in 2020, then tumbled 96.62% in 2022.
  • SELLAS Life Sciences' Other Non-Current Liabilities stood at $4.9 million in 2019, then fell by 5.68% to $4.6 million in 2020, then plummeted by 93.61% to $296000.0 in 2021, then plummeted by 42.57% to $170000.0 in 2022.
  • Per Business Quant, the three most recent readings for SLS's Other Non-Current Liabilities are $170000.0 (Q3 2022), $181000.0 (Q2 2022), and $296000.0 (Q1 2022).